Recherche
-
Efficacy and safety of intravenous immunoglobulin with rituximab versus rituximab alone in childhood-onset steroid-dependent and frequently relapsing nephrotic syndrome: protocol for a multicentre randomised controlled trial
(BMJ Open. vol. 10, n° 9, pp. e037306, 2020)Article de revueLibre accès -
Genetic Insights on the Relation of Vascular Risk Factors and Cervical Artery Dissection
(Journal of the American College of Cardiology. vol. 82, n° 14, pp. 1411-1423, 2023-10-03)Article de revue -
Imatinib Optimized Therapy Improves Major Molecular Response Rates in Patients with Chronic Myeloid Leukemia
(Pharmaceutics. vol. 14, n° 8, pp. 1676, 2022-08-12)Article de revueLibre accès -
Discriminative value of different combinations of tests to detect unilateral neglect in patients with right hemisphere damage.
(European Journal of Neurology. vol. 30, n° 10, pp. 3332-3340, 2023-10-01)Article de revue -
Genome-wide association meta-analysis of spontaneous coronary artery dissection identifies risk variants and genes related to artery integrity and tissue-mediated coagulation
(Nature Genetics. vol. 55, pp. 964-972, 2023-05-29)Article de revueLibre accès -
Real-life omalizumab exposure and discontinuation in a large nationwide population-based study of pediatric and adult asthmatics
(European Respiratory Journal, 2022-05-26)Article de revueLibre accès -
Impact d’une prise en charge par hypnose sur le vécu et l’observance des recommandations hydriques en hémodialyse : résultats d’un protocole à cas unique chez deux patients
(Pratiques Psychologiques, 2021-06-16)Article de revue -
Dasatinib dose optimisation based on therapeutic drug monitoring reduces pleural effusion rates in chronic myeloid leukaemia patients
(British Journal of Haematology. vol. 194, n° 2, pp. 393-402, 2021-06-30)Article de revue -
Regorafenib-avelumab combination in patients with biliary tract cancer (REGOMUNE): a single-arm, open-label, phase II trial
(European Journal of Cancer. vol. 162, pp. 161-169, 2022-02)Article de revue